TRCT
GMDA

Tower Research Capital (TRC)’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History

Tower Research Capital (TRC)’s Portfolio GMDA Stock Details GMDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-19,417
Closed -$25K – 6480
2022
Q4 		$25K Buy
19,417
+13,151
+210% +$20.8K ﹤0.01% 2941
2022
Q3 		$10K Sell
6,266
-9,188
-59% -$20.9K ﹤0.01% 4598
2022
Q2 		$27K Buy
15,454
+11,084
+254% +$28.2K ﹤0.01% 3491
2022
Q1 		$18K Sell
4,370
-3,894
-47% -$13.1K ﹤0.01% 3659
2021
Q4 		$21K Buy
8,264
+3,999
+94% +$13.2K ﹤0.01% 3632
2021
Q3 		$17K Sell
4,265
-688
-14% -$3.44K ﹤0.01% 3895
2021
Q2 		$32K Buy
4,953
+1,937
+64% +$13.4K ﹤0.01% 3433
2021
Q1 		$25K Buy
3,016
+2,644
+711% +$24.3K ﹤0.01% 3724
2020
Q4 		$3K Sell
372
-9,068
-96% -$61.4K ﹤0.01% 4842
2020
Q3 		$39K Buy
+9,440
New +$40.2K ﹤0.01% 3645
2020
Q1 		– Sell
-1,394
Closed -$6K – 4115
2019
Q4 		$6K Buy
1,394
+735
+112% +$3.5K ﹤0.01% 2632
2019
Q3 		$3K Sell
659
-218
-25% -$887 ﹤0.01% 3608
2019
Q2 		$4K Buy
+877
New +$6.88K ﹤0.01% 3076

Other funds holding GMDA

MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
KHLMVGHM
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Tel Aviv, Israel $1.53B AUM 20.88% 1-Year Est. Return
KHLMTHM
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet Tel Aviv, Israel $506M AUM 21.19% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
YAVAPFMC
Yahav Achim Ve Achayot - Provident Funds Management Company Tel-Aviv, Israel $144M AUM 82.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Tower Research Capital (TRC)'s GMDA Position: Q1 2023 in Review

Tower Research Capital (TRC) sold out of Gamida Cell Ltd. Ordinary Shares (GMDA) in Q1 2023, closing a stake of 19,417 shares — an estimated $25K sold.

Tower Research Capital (TRC) first reported a position in GMDA in Q2 2019 and held it in 13 quarters. The position peaked at $39K in Q3 2020. 44 funds tracked by Wall St. Rank hold GMDA as of Q1 2023.

  • Tower Research Capital (TRC) reported no remaining Gamida Cell Ltd. Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 19,417 Gamida Cell Ltd. Ordinary Shares shares in Q1 2023, an estimated $25K.
  • Tower Research Capital (TRC) first reported a position in Gamida Cell Ltd. Ordinary Shares in Q2 2019 and held it in 13 quarters.
  • Tower Research Capital (TRC)'s Gamida Cell Ltd. Ordinary Shares position peaked at $39K in Q3 2020.
  • 44 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q1 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.